Sarah Nelson, MD, MPH, FAAN, FNCS

Neurointensivist, mother, daughter, sister, wife, public health advocate, sports fan. Tweets are my own views.

[SCCM Neuroscience Section @SCCM_Neuro]

SAVE THE DATE!!! 🧠

Our next webinar will be a journal club - "Early Blood Pressure Targets in Acute Spinal Cord Injury: A Randomized Clinical Trial "

Thursday, June 18, 3PM CST - Zoom link to be posted on Connect.

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[SCCM Neuroscience Section @SCCM_Neuro]

"We suggest that either prophylactic ASM or no ASM be used for seizure prophylaxis in patients undergoing supratentorial neurosurgery. If an ASM is used, we suggest LEV over PHT for a short duration."🧠

https://t.co/Cmiego4iHM

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[Sarah Nelson, MD, MPH, FAAN, FNCS @senelson13]

Also joined by the excellent Jen Hurley! A terrific episode!

[American Neurological Association @ANAneurology]

How did ANA Investigates become a leading voice in academic neurology?🎙️🧠
Host & new Executive Producer Dr. @ifrahzawar is joined by Drs. Adeline Goss, Megan Richie, and Romer Geocadin to reflect on the podcast’s origins and evolution since 2019.

🎧 https://t.co/ithyDO7dKd

[NEJM @NEJM]

Among patients with stroke due to medium-vessel occlusion, thrombectomy led to functional independence at 90 days (in 58.6% of patients, vs. 46.6% with medical management) but also to a higher risk of intracranial hemorrhage. Full ORIENTAL-MeVO trial results: https://t.co/FvyLPQz4CV

Editorial: Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population https://t.co/hnLi0DvzuF

[SCCM Neuroscience Section @SCCM_Neuro]

Hematoma evacuation efficacy may mediate the association between mean hematoma density and in-hospital mortality in pts w/ ICH undergoing minimally invasive surgery.🧠

https://t.co/MDEB7qOOWx

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[Sarah Nelson, MD, MPH, FAAN, FNCS @senelson13]

Deeply appreciate the work of my co-authors and AHA staff. We very much hope that the information we present is helpful towards achieving equitable stroke functional outcomes for all. 🙏 @StrokeAHA_ASA @TuftsMCNeuro

[AHA Science @AHAScience]

Sustained improvements in stroke recovery and secondary prevention depend on organizational capacity, equitable implementation based on need, and supportive community and policy infrastructure. Without these broader supports, patient-level interventions are unlikely to be effective or lasting

✍🏼 @senelson13 @MonaBahouth @hayman_ll

[European Stroke Org @ESOstroke]

🚨 #ESOC2026 Late-breaking: The LATE-MT trial shows improved 90-day outcomes in patients with large vessel occlusion (LVO) treated with EVT between 24–72 hours after stroke onset.

@ESOstroke #Stroke #EVT #Thrombectomy #LVO

[European Stroke Org @ESOstroke]

🚨 The ATTRACTION trial at #ESOC2026 shows adjunct tirofiban after successful thrombectomy improves outcomes in acute ischaemic stroke.

✅ 49.3% vs 43.3% functional independence (90 days)
📈 Significant benefit (RR 1.15; p=0.01)
🧠 No increase in sICH or mortality

@ESOstroke

[European Stroke Org @ESOstroke]

ATLAS meta-analysis of 6 trials on EVT for large core infarcts confirms large treatment effect of EVT, reducing disability and mortality, with a NNT of 4,2.

Treatment benefit was consistent over clinical and most imaging subgroups.

@ESOstroke #VoiceOfStroke #Stroke #ESOC2026

[European Stroke Org @ESOstroke]

🚨 New #ESOC2026 trial results

Early administration of tirofiban after insufficient response to IV thrombolysis improved 90-day functional outcomes in acute ischemic stroke patients without increasing symptomatic ICH or mortality.

#Stroke #AcuteStroke #Thrombolysis @ESOstroke

[SCCM Neuroscience Section @SCCM_Neuro]

SAVE THE DATE!!!🧠

Our next monthly Neuroscience Webinar will be on Thursday, May 21, 3-4PM CST:

"Leading Early, Rising Wisely: Leadership and the Art of Gentle Self-Promotion for Early Career Neurointensivists"

Zoom info on Connect.

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[Sarah Nelson, MD, MPH, FAAN, FNCS @senelson13]

Amazing, Flavia, congrats!! @TuftsMedicine

[Soma Sengupta @SomaSen79612182]

Today, Laura C. Duncan and I had the opportunity to visit the Framingham practice. A highlight for me was hand-delivering a card signed by Dr. Erika Werner and Dr. Helen Boucher to Dr. Flavia Machado in recognition of her outstanding outpatient clinical care. @TuftsMCNeuro

[American Neurological Association @ANAneurology]

What is the true financial value of an academic neurologist? 📊🧠
Join us on Friday, May 8, 5–6 PM EDT for a live webinar exploring RVUs, compensation trends, and the broader impact of academic neurology.

🔗 Register Now: https://t.co/TnxPuFHt8m

[Neurology Journal @GreenJournal]

This retrospective observational study found that in patients receiving mechanical thrombectomy for large vessel occlusion #stroke, blood pressure drops during the first 24 hours after groin puncture are common and associated with worse functional outcome: https://t.co/0vMB1YINHt

[SCCM Neuroscience Section @SCCM_Neuro]

EVT for anterior cerebral artery occlusion is associated w/ better clinical outcomes compared w/ SMM, particularly in pts w/ mod-severe stroke, w/o increased risk of symptomatic ICH or 90d mortality.🧠

https://t.co/HVkw1mWYSs

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[NEJM @NEJM]

Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo. Full TRIDENT trial results: https://t.co/0tiij1H7tb

Editorial: Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling https://t.co/Me1YWely2x

[American Neurological Association @ANAneurology]

Is iNPH a distinct clinical syndrome—or still an open question in neurology? 🧠💧
Drs. Alberto Espay & Michael Williams join Dr. Kara Wyant in ANA Investigates to unpack diagnosis, management, & ongoing debates, along with insights from the PENS trial.

🎧 https://t.co/9Q1qbBx2EU

[Nick Murray @NickMurray_]

Our new paper in Neurocritical Care presents the first TeleNCC Consensus Statement—defining best practice, minimum standards, and benchmarks for teleneurocritical care.
Here are the key takeaways 👇
#TeleNCC #NeurocriticalCare #Stroke @Intermountain https://t.co/bbYGPYB9Ki

[NEJM @NEJM]

In the phase 3 OCEANIC-STROKE trial involving patients with noncardioembolic ischemic stroke or high-risk TIA, asundexian added to antiplatelet therapy led to a lower risk of ischemic stroke without increasing major bleeding. Full trial results: https://t.co/UPJGedYXFe

Editorial: Asundexian for Noncardioembolic Ischemic Stroke https://t.co/V1dVNbx4T8

[Tufts Medical Center @TuftsMedicalCtr]

Study in @JAMANeuro co-authored by Tufts Medicine + @TuftsMedSchool neurologists: PASCAL system identifies stroke patients who benefit from PFO closure.

Learn more: https://t.co/FzgOH8ekee